Given the abnormal expression of CHK1 in tumor cells, it is intriguing to explore whether changes in CHK1 expression and activity are related to phosphorylation and ubiquitination, which could provide new insights into chemotherapeutic drugs targeting CHK1 for anti-cancer therapy. Here, CHEK1 is linked to neoplasm.